AXA Framlington Biotech Fund R USD Acc
ISIN GB00BZ3T0190 / Valor 32448531
AXA Framlington Biotech Fund R USD Acc
UMushroom community rating:
The AXA Framlington Biotech Fund primarily invests in listed biotechnology, genomic, and medical research companies, allocating at least 80% of its assets to this sector. It targets firms of all sizes around the world, with a strong emphasis on U.S.-based biotechnology companies. The fund carefully selects its investments based on each company’s financial health, management quality, profitability, and growth prospects, aiming to achieve long-term capital growth by focusing on businesses poised for above-average returns in the biotech industry.
Ratings & reviews
OTHER SHARE CLASSES OF THIS FUND
